20-30kDa (Reducing)
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1735-40.
2.Yang D, Holt GE, Velders MP, Kwon ED, Kast WM. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res. 2001 Aug 1;61(15):5857-60.
Prostate stem cell antigen (PSCA), a cell-membrane glycoprotein composed of 123 amino acids, is frequently expressed in prostate cancer. Mouse PSCA (mPSCA) exhibits 65% homology with human PSCA at both the nucleotide and amino acid levels. The knockdown of PSCA has been shown to induce epithelial-mesenchymal transition (EMT) and to reduce the metastatic potential of DU145 cells, indicating a significant role for PSCA in the carcinogenesis and progression of prostate cancer.
1μg (R: reducing condition, N: non-reducing condition).
The purity of PSCA His Tag Protein, Mouse is more than 90% determined by SEC-HPLC.